Haemostasis is now generally accepted to be a dynamic mechanism. In injury, haemostasis is effected by a series of processes resulting finally in the formation of a blood clot. This process involves capillary retraction whereby the severed vessel end is narrowed; this is followed by the accretion of an occlusive platelet thrombus, and finally the formation of a clot in the now static blood. Pro- gression of this process is probably limited and controlled by the increased production of antithrombin (and probably of other natural inhibitors), and by the fibrinolytic mechanism so that thrombus formation does not undergo retrograde spread to involve the whole vascular tree. The fibrinolytic mechanism is also reparative and is active in the healing process. In normal health a fine balance between the haemostatic and fibrinolytic systems is said to maintain the integrity of the organism (Mole, 1948; Copley, 1954; Astrup, 1956 a and b; Jensen, 1956) .
The clotting process is a complex series of reations in three main stages (Fig. 1) . These stages involve the production of intrinsic thromboplastin, which activates prothrombin to thrombin, and this in turn converts fibrinogen to fibrin.
The fibrinolytic system produces plasmin from the soluble globulin precursor plasminogen in the blood. This reaction is controlled by activators which are present in the blood and tissues, and the active enzyme is released in excess at the site of injury. The plasmin so produced normally degrades fibrin (Fig. 2 ).
An insufficiency of one or more of the clotting factors can occur from (1) consumption, because inadequate anticoagulation may allow clot formation to occur, and (2) In extracorporeal circuits the maintenance of an incoagulable blood requires the addition of an anticoagulant, heparin being customarily used for this purpose. Post-operatively, the anticoagulant effect of heparin is reversed by an antagonist such as hexadimethrine bromide so that normal haemostasis is restored.
Reports on changes in the coagulation mechanism after the use of an extracorporeal circulation are numerous and variable, a reduction in platelets being the commonest change recorded (Bloom, 1961) . Fibrinogenopenia and excessive fibrinolysis, although frequently described, have not been inevitable (Osborn, MacKenzie, Shaw, Perkins, Hurt, and Gerbode, 1956) . Depression in blood factor VIII levels (Hoeksema, Mustard, and Mustard, 1959; Smith, Brown, Young, and Sealy, 1959) has not been constant (Bloom, 1961; Matzke, Jensen, and Rygg, 1961) Table I. GROUP Iii This group consisted of 36 mongrel dogs of both sexes, ranging in weight from 9-7 to 26-3 kg.
Of these, six were subjected to anaesthesia only, 10 to anaesthesia and thoracotomy, and 20 to standard cardiopulmonary bypass.
METHODS
The method of extracorporeal circulation, using a Melrose N.E.P. rotating disc oxygenator, has previously been described (MacKenzie, Davies, Masson, and Wade, 1963) .
Healthy mongrel dogs were used as blood donors in the animal experiments. After heparinization (3 mg./ kg.) they were exsanguinated under anaesthesia. Blood was collected under sterile conditions through plastic tannulae into siliconed M.R.C. bottles!; the anticoagulant used was 30 mg. heparin in 15 ml. sterile normal saline, 400 ml. of blood being drawn into each bottle. Donations were made on the morning of operation. In the early dog experiments, donors and the operation animal were cross-matched and intermatched.
Routine human donor blood was always collected on the morning of operation, 400 ml. being drawn from each donor into similar anticoagulant and containers. The blood was kept at 4°C. until the priming of the machine. Donors had previously been routinely screened for abnormal antibodies, cross-matched with the patient, and intermatched among themselves.
Group III dogs were used to determine the heparinneutralizing dose of hexadimethrine bromide and to determine the degree of influence, if any, of anaes- 4d in all cases. lPre-anaesthetic.
-thesia alone, of anaesthesia with surgery, and finally of anaesthesia with bypass on this ratio. Subjects, both dog and human, were heparinized immediately before cannulation of the venae cavae, using 3 mg./kg. body weight. Hexadimethrine bromide was given approximately one to one-and-a-half hours after heparinization in all groups, the drug being administered diluted in 100 to 200 ml. 5°/. dextrose and given over not less than 10 minutes to avoid circulatory upset (MacKenzie, Wade, Davies, and Zellos, 1961) . Additional doses were given as indicated in a similar manner. Neutralization of heparin was thought to be complete when the thrombin time had returned to the approximate preheparinization level and was not further shortened by the prior addition of toluidine blue to the plasma (Rothnie and Kinmonth, 1960b) . In all other experiments hexadimethrine bromide was used in the same manner, and adequacy of neutralization was determined by the same criteria.
All the subjects. both animal and human, had a full preliminary blood count and were investigated by determination of their clotting times both in plain and in siliconed glass tubes, their prothrombin time, prothrombin consumption index, thrombin time before and after toluidine blue, Russell's viper venom time, thromboplastin generation test, and in some animals (and in all the humans) by assaying the blood factor VIII level. Bleeding time and Hess test were done in humans. Some of these parameters were repetitively monitored throughout the operation. During perfusion heparinization was thought to be adequate when a thrombin time of not less than 60 seconds (the control being 10 to 12 seconds) and a clotting time (Lee and White) of not less than 60 minutes were found. At the end of perfusion a full coagulation screening was done, and repeated, if necessary, until reversal with hexadimethrine bromide was considered complete. Thereafter a modified haematological and coagulation screening was repeated as required on the day of operation and then at regular intervals for 14 days post-operatively.
Standard blood counts were done according to the methods of Dacie (1956) . The glass and silicone-treated glass clotting times, Ivy bleeding time, Hess test, Quick prothrombin time, prothrombin consumption index. thrombin time before and after toluidine blue, and recalcification time of oxalated plasma were done by the methods of Biggs and Macfarlane (1962) . Russell's viper venom time was done according to Fullerton (1940) and factor VIII assay and thromboplastin generation test as described by Biggs, Eveling, and Richards (1955) and Biggs and Douglas (1953) respectively. The 'fibrinolytic' and/or 'activator' activity was measured by a plasma euglobulin lysis time (Macfarlane and Pilling, 1946) giving in our laboratory a normal value of more than 80 minutes. The antifibrinolysins were measured by their ability to inhibit the action of serial dilutions of plasmin (in our case 'thrombolysin') on a clot indicator system (Biezenski, 1960) . The normal range in our hands was found to be 1/18 to 1/10 titres. The technique of modified methods as applied in this study has been recently described (Kamel, 1963) . The fibrinogen was assayed by a Kjeldahl technique (N=200-500 mg.%).
The results of our experiments are summarized in the accompanying figures and tables.
DISCUSSION
Platelets occupy a central position in relation to the problem of haemostasis in cardiopulmonary bypass. In vivo they function in both thrombogenic and coagulation systems; in the former, by undergoing viscous metamorphosis, they produce a platelet plug, and in the latter they release platelet factor 3 (co-factor 3), which participates in the early stages of the clotting mechanism (Alexander, 1962) . As long ago as 1938 Best, Cowan, and Maclean found that inhibition of viscous metamorphosis required a much larger dose of heparin than that required to inhibit the release of co-factor 3. Heparin, which is still the most suitable anticoagulant for cardiopulmonary bypass, is limited in dose by the need to neutralize it post-operatively by either protamine sulphate or hexadimethrine bromide, both of which are potentially toxic in excess, and are themselves anticoagulants in vitro in high concentrations (Preston, 1952; Perkins et al., 1961) . The neutralizing ratio of hexadimethrine bromide, now most generally used as the heparin antagonist, has steadily risen since the first clinical studies by Preston, Hohf, and Trippel in 1956. These authors recommended a 0-7:1 dose ratio of hexadimethrine bromide to heparin; Weiss, Gilman, Catenacci, and Osterberg (1958) ratio may not always be adequate. Heparin, 30 mg., in 400 ml. of blood is still inadequate to prevent platelet loss (Table III) , and there is a further progressive loss on storage (Baldini, Costea, and Dameshek, 1960 therefore, to collect blood on the morning of operation rather than the night before, and this is in agreement with recent findings (Botha and Barnard, 1962) . The extensive area of foreign surface in the extracorporeal circuit, despite the effect of siliconization to reduce water wettability, produces a pronounced platelet loss through platelet adhesion even with freshly collected blood (Table   III ), but we found that further platelet loss does not follow proportionately to the duration of bypass (Fig. 3) , in contrast to the findings of Gans and Krivit (1962) post-operatively by depriving him of their action in the thrombogenic phase of haemostasis. However, this platelet adhesion might also release a quantity of co-factor 3 into the extracorporeal circuit during the bypass and thereby minimally activate the coagulation mechanism with consumption of clotting factors and thus possibly activate the fibrinolytic mechanism. Neither the clotting factor loss nor the increased fibrinolysis might be evident until neutralization of heparin had been effected at the end of bypass.
The minimal platelet count post-operatively occurs at a varying time (Table IV) , ranging in these four patients from day 1 to day 4-5, and this could be attributed to mechanical damage to the platelets in the pump with their subsequent shortened survival. We found no evidence, by inference from red cell compatibility tests (Table  V) , that this might be a platelet antigen/antibody (145-400) (39-430) (20-220) Counts are in 103,'mm3.; ranges are given in parentheses.
reaction, and our results (Fig. 4) suggest that the red cells suffer trauma in the pump that is directly related to perfusion time, the rise in plasma haemoglobin being proportional to the length of perfusion. A shortening of the thrombin time is indicative of loss of circulating heparin, presumably due either to its utilization or to its shift into the tissues. Thus a shortened thrombin time, if not corrected by the addition of further heparin, will presage the activation of the clotting mechanism and the consumption of clotting factors including fibrinogen and factor VIII. Using heparin in a dose (Table VI) . This is in contrast with t factor VIII levels described by othe (Hoeksema et al., 1959; Smith et that the )peratively Our experimental work suggests that the neutralnstitutes a izing dose of hexadimethrine bromide for heparin :ause toxic should be based on a 2: 1 ratio. The role of )mbin time platelets in the haemostatic mechanism and in rvals while particular in relation to extracorporeal cardior doses of pulmonary bypass is discussed. We suggest that 60 seconds. adequate heparinization must be maintained to a minimal minimize platelet loss and to minimize activation ay likewise of the clotting mechanism and hence the fibrinohe fibrino-lytic mechanism. We think that regular thrombin 
